Tag: Asundexian
Market: Bayer falls after the clinical failure of its anticoagulant Asundexian
(Reuters) – Bayer fell on the stock market on Monday morning after announcing the day before the abandonment of a large phase III clinical trial involving a new anticoagulant drug,…
Bayer cancels study on hopeful Asundexian
Should reduce risk of stroke Bayer cancels study on hopefuls November 20, 2023, 7:39 a.m Listen to article This audio version was artificially generated. More info | Send feedback Taking…